The Enterprise Value as of December 2025 (TTM) for Amplia Therapeutics Limited (INNMF) is 53.28M

According to Amplia Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 53.28M. This represents a change of 182.43% compared to the average of 18.87M of the last 4 quarters.

Amplia Therapeutics Limited (INNMF) Historical Enterprise Value (quarterly & annually)

How has INNMF Enterprise Value performed in the past?

The mean historical Enterprise Value of Amplia Therapeutics Limited over the last ten years is 27.14M. The current 53.28M Enterprise Value has changed 19.54% with respect to the historical average. Over the past ten years (40 quarters), INNMF's Enterprise Value was at its highest in in the March 2017 quarter at 145.70M. The Enterprise Value was at its lowest in in the March 2011 quarter at -483539.00.

Amplia Therapeutics Limited (INNMF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amplia Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amplia Therapeutics Limited (INNMF) Average Enterprise Value

How has INNMF Enterprise Value performed in the past?

The current Enterprise Value of Amplia Therapeutics Limited (INNMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Amplia Therapeutics Limited (INNMF) Enterprise Value vs. Peers

How is INNMF’s Enterprise Value compared to its peers?

Amplia Therapeutics Limited’s Enterprise Value is greater than Relief Therapeutics Holding AG (24.05M), less than Oncotelic Therapeutics, Inc. (58.52M), greater than Relief Therapeutics Holding AG (24.05M), greater than PsyBio Therapeutics Corp. (135.91K), less than Helix BioPharma Corp. (178.01M), greater than ZIVO Bioscience, Inc. (39.26M), less than Arch Biopartners Inc. (86.23M), less than Calliditas Therapeutics AB (publ) (11.24B), less than Cynata Therapeutics Limited (59.06M), greater than Covalon Technologies Ltd. (37.47M),

Build a custom stock screener for Amplia Therapeutics Limited (INNMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amplia Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amplia Therapeutics Limited (INNMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amplia Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.